X4 Pharmaceuticals Inc (XFOR) — Financial Flexibility Index
X4 Pharmaceuticals Inc (XFOR) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $0.00 (operating CF $-19.60 Million minus capex $19.60 Million) represents 0% of total liabilities ($101.83 Million). Check strategic asset allocation of X4 Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
X4 Pharmaceuticals Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for X4 Pharmaceuticals Inc across 11 annual periods. See XFOR net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for X4 Pharmaceuticals Inc (2015–2025)
Year-by-year free cash flow to debt coverage for X4 Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of X4 Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.79x | $-82.62 Million | $-85.62 Million | $104.17 Million | ▲ +20.2% |
| 2024 | -0.99x | $-123.58 Million | $-130.90 Million | $124.30 Million | ▲ +0.9% |
| 2023 | -1.00x | $-96.45 Million | $-96.51 Million | $96.16 Million | ▼ -6.2% |
| 2022 | -0.94x | $-77.00 Million | $-77.10 Million | $81.53 Million | ▲ +29.1% |
| 2021 | -1.33x | $-70.29 Million | $-70.91 Million | $52.76 Million | ▼ -16.1% |
| 2020 | -1.15x | $-57.46 Million | $-58.82 Million | $50.07 Million | ▲ +24.6% |
| 2019 | -1.52x | $-47.88 Million | $-48.05 Million | $31.48 Million | ▲ +13.7% |
| 2018 | -1.76x | $-25.39 Million | $-25.42 Million | $14.40 Million | ▼ -42.8% |
| 2017 | -1.23x | $-27.83 Million | $-27.87 Million | $22.55 Million | ▼ -39.2% |
| 2016 | -0.89x | $-21.57 Million | $-21.64 Million | $24.33 Million | ▼ -15.6% |
| 2015 | -0.77x | $-10.65 Million | $-10.82 Million | $13.88 Million | — |